nodes	percent_of_prediction	percent_of_DWPC	metapath
Omeprazole—ABCB1—adrenal gland cancer	0.753	1	CbGaD
Omeprazole—CYP11A1—zona fasciculata of adrenal gland—adrenal gland cancer	0.0807	0.378	CbGeAlD
Omeprazole—CYP11A1—zona glomerulosa of adrenal gland—adrenal gland cancer	0.0705	0.331	CbGeAlD
Omeprazole—CYP2C19—urine—adrenal gland cancer	0.00689	0.0323	CbGeAlD
Omeprazole—CYP1A2—urine—adrenal gland cancer	0.00563	0.0264	CbGeAlD
Omeprazole—CYP2C9—urine—adrenal gland cancer	0.00535	0.025	CbGeAlD
Omeprazole—ATP4A—adrenal cortex—adrenal gland cancer	0.00523	0.0245	CbGeAlD
Omeprazole—CYP3A4—urine—adrenal gland cancer	0.00408	0.0191	CbGeAlD
Omeprazole—CYP2D6—urine—adrenal gland cancer	0.00401	0.0188	CbGeAlD
Omeprazole—ATP4A—adrenal gland—adrenal gland cancer	0.00377	0.0177	CbGeAlD
Omeprazole—CYP11A1—adrenal cortex—adrenal gland cancer	0.00343	0.0161	CbGeAlD
Omeprazole—CYP11A1—gonad—adrenal gland cancer	0.00284	0.0133	CbGeAlD
Omeprazole—ABCC3—adrenal cortex—adrenal gland cancer	0.00266	0.0125	CbGeAlD
Omeprazole—CYP11A1—adrenal gland—adrenal gland cancer	0.00247	0.0116	CbGeAlD
Omeprazole—Pantoprazole—ABCB1—adrenal gland cancer	0.00219	0.573	CrCbGaD
Omeprazole—ABCC3—adrenal gland—adrenal gland cancer	0.00192	0.009	CbGeAlD
Omeprazole—CYP1B1—gonad—adrenal gland cancer	0.00172	0.00808	CbGeAlD
Omeprazole—CYP1B1—pituitary gland—adrenal gland cancer	0.00168	0.00788	CbGeAlD
Omeprazole—Lansoprazole—ABCB1—adrenal gland cancer	0.00164	0.427	CrCbGaD
Omeprazole—ABCG2—adrenal cortex—adrenal gland cancer	0.00155	0.00726	CbGeAlD
Omeprazole—CYP1B1—adrenal gland—adrenal gland cancer	0.0015	0.00704	CbGeAlD
Omeprazole—CYP2C8—pituitary gland—adrenal gland cancer	0.00129	0.00604	CbGeAlD
Omeprazole—ABCG2—pituitary gland—adrenal gland cancer	0.00125	0.00587	CbGeAlD
Omeprazole—CYP1A1—cardiac atrium—adrenal gland cancer	0.00122	0.0057	CbGeAlD
Omeprazole—ABCG2—adrenal gland—adrenal gland cancer	0.00112	0.00524	CbGeAlD
Omeprazole—ABCG2—Fluoropyrimidine Activity—RRM1—adrenal gland cancer	0.000976	0.0331	CbGpPWpGaD
Omeprazole—ABCB1—adrenal cortex—adrenal gland cancer	0.000764	0.00358	CbGeAlD
Omeprazole—CYP2D6—Codeine and Morphine Metabolism—ABCB1—adrenal gland cancer	0.000668	0.0226	CbGpPWpGaD
Omeprazole—CYP11A1—Endogenous sterols—POMC—adrenal gland cancer	0.000666	0.0226	CbGpPWpGaD
Omeprazole—ABCB1—gonad—adrenal gland cancer	0.000633	0.00297	CbGeAlD
Omeprazole—ABCC3—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.000627	0.0213	CbGpPWpGaD
Omeprazole—ABCB1—pituitary gland—adrenal gland cancer	0.000618	0.00289	CbGeAlD
Omeprazole—ABCC3—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	0.000598	0.0202	CbGpPWpGaD
Omeprazole—ABCC3—ABC-family proteins mediated transport—ABCB1—adrenal gland cancer	0.000571	0.0193	CbGpPWpGaD
Omeprazole—ABCB1—adrenal gland—adrenal gland cancer	0.000552	0.00259	CbGeAlD
Omeprazole—CYP11A1—Metabolism of steroid hormones and vitamin D—POMC—adrenal gland cancer	0.000499	0.0169	CbGpPWpGaD
Omeprazole—CYP3A4—Codeine and Morphine Metabolism—ABCB1—adrenal gland cancer	0.000437	0.0148	CbGpPWpGaD
Omeprazole—CYP11A1—Prostaglandin Synthesis and Regulation—PTGS2—adrenal gland cancer	0.00043	0.0146	CbGpPWpGaD
Omeprazole—CYP1B1—Endogenous sterols—POMC—adrenal gland cancer	0.000425	0.0144	CbGpPWpGaD
Omeprazole—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—PRKACA—adrenal gland cancer	0.000387	0.0131	CbGpPWpGaD
Omeprazole—CYP11A1—Corticotropin-releasing hormone—GNAS—adrenal gland cancer	0.000326	0.0111	CbGpPWpGaD
Omeprazole—CYP11A1—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.000309	0.0105	CbGpPWpGaD
Omeprazole—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—ABCB1—adrenal gland cancer	0.000308	0.0104	CbGpPWpGaD
Omeprazole—CYP2C18—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.000268	0.00907	CbGpPWpGaD
Omeprazole—CYP11A1—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.000251	0.00849	CbGpPWpGaD
Omeprazole—ATP4B—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.000249	0.00842	CbGpPWpGaD
Omeprazole—ABCG2—HIF-1-alpha transcription factor network—ABCB1—adrenal gland cancer	0.000242	0.00821	CbGpPWpGaD
Omeprazole—CYP2C19—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.00024	0.00812	CbGpPWpGaD
Omeprazole—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—adrenal gland cancer	0.000239	0.0081	CbGpPWpGaD
Omeprazole—CYP1B1—Aryl Hydrocarbon Receptor—RB1—adrenal gland cancer	0.000237	0.00802	CbGpPWpGaD
Omeprazole—ATP4A—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.000222	0.00751	CbGpPWpGaD
Omeprazole—CYP11A1—Corticotropin-releasing hormone—POMC—adrenal gland cancer	0.00022	0.00744	CbGpPWpGaD
Omeprazole—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.000218	0.0074	CbGpPWpGaD
Omeprazole—CYP11A1—Corticotropin-releasing hormone—BRAF—adrenal gland cancer	0.000217	0.00735	CbGpPWpGaD
Omeprazole—CYP2C18—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.000217	0.00735	CbGpPWpGaD
Omeprazole—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PRKACA—adrenal gland cancer	0.000209	0.00708	CbGpPWpGaD
Omeprazole—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	0.000208	0.00705	CbGpPWpGaD
Omeprazole—ABCG2—HIF-1-alpha transcription factor network—TERT—adrenal gland cancer	0.000207	0.00703	CbGpPWpGaD
Omeprazole—ATP4B—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.000201	0.00683	CbGpPWpGaD
Omeprazole—ABCC3—Fluoropyrimidine Activity—TP53—adrenal gland cancer	0.000199	0.00675	CbGpPWpGaD
Omeprazole—ATP4B—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.000198	0.0067	CbGpPWpGaD
Omeprazole—CYP1B1—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.000197	0.00668	CbGpPWpGaD
Omeprazole—CYP1B1—Aryl Hydrocarbon Receptor—PTGS2—adrenal gland cancer	0.000195	0.00659	CbGpPWpGaD
Omeprazole—CYP1A1—PPARA activates gene expression—MED12—adrenal gland cancer	0.000188	0.00637	CbGpPWpGaD
Omeprazole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—MED12—adrenal gland cancer	0.000184	0.00623	CbGpPWpGaD
Omeprazole—CYP1B1—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	0.000182	0.00617	CbGpPWpGaD
Omeprazole—ATP4A—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.00018	0.00608	CbGpPWpGaD
Omeprazole—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	0.000178	0.00603	CbGpPWpGaD
Omeprazole—ATP4A—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.000176	0.00597	CbGpPWpGaD
Omeprazole—CYP1B1—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00016	0.00542	CbGpPWpGaD
Omeprazole—CYP11A1—Corticotropin-releasing hormone—CTNNB1—adrenal gland cancer	0.000157	0.00531	CbGpPWpGaD
Omeprazole—CYP1A1—Aryl Hydrocarbon Receptor—RB1—adrenal gland cancer	0.000146	0.00494	CbGpPWpGaD
Omeprazole—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.000144	0.00488	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—DAXX—adrenal gland cancer	0.000139	0.00472	CbGpPWpGaD
Omeprazole—CYP1B1—Aryl Hydrocarbon Receptor—EGFR—adrenal gland cancer	0.000138	0.00467	CbGpPWpGaD
Omeprazole—CYP1B1—Aryl Hydrocarbon Receptor Pathway—EGFR—adrenal gland cancer	0.000138	0.00467	CbGpPWpGaD
Omeprazole—ABCG2—Fluoropyrimidine Activity—TP53—adrenal gland cancer	0.000137	0.00466	CbGpPWpGaD
Omeprazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	0.000137	0.00465	CbGpPWpGaD
Omeprazole—CYP11A1—Biological oxidations—POMC—adrenal gland cancer	0.000133	0.00451	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—RRM1—adrenal gland cancer	0.000129	0.00439	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.000128	0.00435	CbGpPWpGaD
Omeprazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—MED12—adrenal gland cancer	0.000127	0.00429	CbGpPWpGaD
Omeprazole—CYP1A1—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.000121	0.00412	CbGpPWpGaD
Omeprazole—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—adrenal gland cancer	0.00012	0.00406	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—SDHB—adrenal gland cancer	0.000119	0.00403	CbGpPWpGaD
Omeprazole—CYP2C18—Biological oxidations—POMC—adrenal gland cancer	0.000115	0.0039	CbGpPWpGaD
Omeprazole—CYP1A1—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	0.000112	0.0038	CbGpPWpGaD
Omeprazole—ABCB1—HIF-1-alpha transcription factor network—TERT—adrenal gland cancer	0.000112	0.0038	CbGpPWpGaD
Omeprazole—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.000111	0.00377	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.000108	0.00366	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—SDHB—adrenal gland cancer	0.000103	0.00349	CbGpPWpGaD
Omeprazole—CYP2C8—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	0.000103	0.00348	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—SDHB—adrenal gland cancer	0.0001	0.0034	CbGpPWpGaD
Omeprazole—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	9.94e-05	0.00337	CbGpPWpGaD
Omeprazole—CYP1A1—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	9.85e-05	0.00334	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	9.37e-05	0.00318	CbGpPWpGaD
Omeprazole—CYP1A2—Aryl Hydrocarbon Receptor—RB1—adrenal gland cancer	9.3e-05	0.00315	CbGpPWpGaD
Omeprazole—CYP2C19—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	9.18e-05	0.00311	CbGpPWpGaD
Omeprazole—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	9.14e-05	0.0031	CbGpPWpGaD
Omeprazole—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	9.07e-05	0.00307	CbGpPWpGaD
Omeprazole—CYP2C8—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	9.03e-05	0.00306	CbGpPWpGaD
Omeprazole—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—adrenal gland cancer	8.5e-05	0.00288	CbGpPWpGaD
Omeprazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—adrenal gland cancer	8.5e-05	0.00288	CbGpPWpGaD
Omeprazole—CYP1B1—Biological oxidations—POMC—adrenal gland cancer	8.5e-05	0.00288	CbGpPWpGaD
Omeprazole—CYP2C9—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	8.37e-05	0.00283	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	8.19e-05	0.00278	CbGpPWpGaD
Omeprazole—CYP2C19—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	8.06e-05	0.00273	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—TOP2A—adrenal gland cancer	8e-05	0.00271	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	7.89e-05	0.00267	CbGpPWpGaD
Omeprazole—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	7.75e-05	0.00262	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—SDHD—adrenal gland cancer	7.67e-05	0.0026	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—RRM1—adrenal gland cancer	7.67e-05	0.0026	CbGpPWpGaD
Omeprazole—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—adrenal gland cancer	7.64e-05	0.00259	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—SDHB—adrenal gland cancer	7.6e-05	0.00257	CbGpPWpGaD
Omeprazole—ABCC3—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	7.5e-05	0.00254	CbGpPWpGaD
Omeprazole—CYP2D6—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	7.41e-05	0.00251	CbGpPWpGaD
Omeprazole—CYP2C9—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	7.35e-05	0.00249	CbGpPWpGaD
Omeprazole—CYP1A2—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	7.15e-05	0.00242	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—SDHB—adrenal gland cancer	6.91e-05	0.00234	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—RRM1—adrenal gland cancer	6.64e-05	0.00225	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—SDHD—adrenal gland cancer	6.64e-05	0.00225	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—RRM1—adrenal gland cancer	6.46e-05	0.00219	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—SDHD—adrenal gland cancer	6.46e-05	0.00219	CbGpPWpGaD
Omeprazole—CYP1A2—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	6.28e-05	0.00213	CbGpPWpGaD
Omeprazole—ABCC3—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	6.08e-05	0.00206	CbGpPWpGaD
Omeprazole—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	5.98e-05	0.00203	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	5.98e-05	0.00203	CbGpPWpGaD
Omeprazole—ABCC3—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	5.97e-05	0.00202	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—MED12—adrenal gland cancer	5.72e-05	0.00194	CbGpPWpGaD
Omeprazole—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—adrenal gland cancer	5.42e-05	0.00184	CbGpPWpGaD
Omeprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—adrenal gland cancer	5.42e-05	0.00184	CbGpPWpGaD
Omeprazole—CYP1A1—Biological oxidations—POMC—adrenal gland cancer	5.23e-05	0.00177	CbGpPWpGaD
Omeprazole—ABCG2—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	5.17e-05	0.00175	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	5.11e-05	0.00173	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	5.05e-05	0.00171	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—MED12—adrenal gland cancer	4.95e-05	0.00168	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—RRM1—adrenal gland cancer	4.89e-05	0.00166	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—SDHD—adrenal gland cancer	4.89e-05	0.00166	CbGpPWpGaD
Omeprazole—CYP3A4—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	4.85e-05	0.00164	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—MED12—adrenal gland cancer	4.82e-05	0.00163	CbGpPWpGaD
Omeprazole—CYP2C8—Biological oxidations—POMC—adrenal gland cancer	4.8e-05	0.00163	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—SDHB—adrenal gland cancer	4.68e-05	0.00158	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	4.63e-05	0.00157	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—RRM1—adrenal gland cancer	4.45e-05	0.00151	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—SDHD—adrenal gland cancer	4.45e-05	0.00151	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	4.3e-05	0.00146	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—SDHB—adrenal gland cancer	4.29e-05	0.00145	CbGpPWpGaD
Omeprazole—CYP2C19—Biological oxidations—POMC—adrenal gland cancer	4.28e-05	0.00145	CbGpPWpGaD
Omeprazole—ABCG2—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	4.19e-05	0.00142	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—PRKACA—adrenal gland cancer	4.17e-05	0.00141	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—adrenal gland cancer	4.17e-05	0.00141	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	4.13e-05	0.0014	CbGpPWpGaD
Omeprazole—ABCG2—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	4.11e-05	0.00139	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	4.08e-05	0.00138	CbGpPWpGaD
Omeprazole—CYP2D6—Biological oxidations—POMC—adrenal gland cancer	3.94e-05	0.00133	CbGpPWpGaD
Omeprazole—CYP2C9—Biological oxidations—POMC—adrenal gland cancer	3.9e-05	0.00132	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—SDHB—adrenal gland cancer	3.83e-05	0.0013	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	3.77e-05	0.00128	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—SDHB—adrenal gland cancer	3.74e-05	0.00127	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	3.68e-05	0.00125	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—MED12—adrenal gland cancer	3.65e-05	0.00124	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—PRKACA—adrenal gland cancer	3.61e-05	0.00122	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—SDHB—adrenal gland cancer	3.52e-05	0.00119	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—PRKACA—adrenal gland cancer	3.51e-05	0.00119	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—SDHB—adrenal gland cancer	3.49e-05	0.00118	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	3.43e-05	0.00116	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—GNAS—adrenal gland cancer	3.38e-05	0.00115	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	3.38e-05	0.00114	CbGpPWpGaD
Omeprazole—CYP1A2—Biological oxidations—POMC—adrenal gland cancer	3.34e-05	0.00113	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—MED12—adrenal gland cancer	3.32e-05	0.00112	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—ABCB1—adrenal gland cancer	3.32e-05	0.00112	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	3.26e-05	0.00111	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	3.22e-05	0.00109	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—adrenal gland cancer	3.07e-05	0.00104	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—RRM1—adrenal gland cancer	3.01e-05	0.00102	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—SDHD—adrenal gland cancer	3.01e-05	0.00102	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	3.01e-05	0.00102	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—SDHB—adrenal gland cancer	2.98e-05	0.00101	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—GNAS—adrenal gland cancer	2.93e-05	0.000992	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—ABCB1—adrenal gland cancer	2.87e-05	0.000973	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—GNAS—adrenal gland cancer	2.85e-05	0.000965	CbGpPWpGaD
Omeprazole—ABCB1—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	2.8e-05	0.000947	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—ABCB1—adrenal gland cancer	2.79e-05	0.000947	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—RRM1—adrenal gland cancer	2.76e-05	0.000936	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—SDHD—adrenal gland cancer	2.76e-05	0.000936	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	2.75e-05	0.000931	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—adrenal gland cancer	2.74e-05	0.000929	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—PRKACA—adrenal gland cancer	2.66e-05	0.000902	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	2.6e-05	0.000882	CbGpPWpGaD
Omeprazole—CYP3A4—Biological oxidations—POMC—adrenal gland cancer	2.57e-05	0.000872	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—RRM1—adrenal gland cancer	2.47e-05	0.000836	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—SDHD—adrenal gland cancer	2.47e-05	0.000836	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—PRKACA—adrenal gland cancer	2.42e-05	0.000821	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—RRM1—adrenal gland cancer	2.41e-05	0.000816	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—SDHD—adrenal gland cancer	2.41e-05	0.000816	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	2.35e-05	0.000795	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—SDHB—adrenal gland cancer	2.3e-05	0.00078	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—POMC—adrenal gland cancer	2.28e-05	0.000772	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—RRM1—adrenal gland cancer	2.27e-05	0.000769	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—SDHD—adrenal gland cancer	2.27e-05	0.000769	CbGpPWpGaD
Omeprazole—ABCB1—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	2.27e-05	0.000768	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—SDHD—adrenal gland cancer	2.25e-05	0.000762	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—RRM1—adrenal gland cancer	2.25e-05	0.000762	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—MED12—adrenal gland cancer	2.25e-05	0.000761	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—adrenal gland cancer	2.17e-05	0.000736	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—GNAS—adrenal gland cancer	2.16e-05	0.000731	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—ABCB1—adrenal gland cancer	2.12e-05	0.000717	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—MED12—adrenal gland cancer	2.06e-05	0.000698	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	2.01e-05	0.000681	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—POMC—adrenal gland cancer	1.97e-05	0.000668	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—GNAS—adrenal gland cancer	1.96e-05	0.000665	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—ABCB1—adrenal gland cancer	1.93e-05	0.000653	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—RRM1—adrenal gland cancer	1.92e-05	0.000651	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—SDHD—adrenal gland cancer	1.92e-05	0.000651	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—POMC—adrenal gland cancer	1.92e-05	0.00065	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	1.84e-05	0.000624	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—MED12—adrenal gland cancer	1.84e-05	0.000623	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	1.82e-05	0.000618	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—PTGS2—adrenal gland cancer	1.82e-05	0.000615	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—MED12—adrenal gland cancer	1.8e-05	0.000608	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—MED12—adrenal gland cancer	1.69e-05	0.000573	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—MED12—adrenal gland cancer	1.68e-05	0.000568	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	1.64e-05	0.000557	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—PRKACA—adrenal gland cancer	1.64e-05	0.000555	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	1.6e-05	0.000543	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—PTGS2—adrenal gland cancer	1.57e-05	0.000533	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—PTGS2—adrenal gland cancer	1.53e-05	0.000518	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—PRKACA—adrenal gland cancer	1.5e-05	0.000509	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	1.5e-05	0.000508	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—RRM1—adrenal gland cancer	1.48e-05	0.000503	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—SDHD—adrenal gland cancer	1.48e-05	0.000503	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	1.47e-05	0.000498	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—POMC—adrenal gland cancer	1.45e-05	0.000492	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—MED12—adrenal gland cancer	1.43e-05	0.000486	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—PRKACA—adrenal gland cancer	1.34e-05	0.000455	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—GNAS—adrenal gland cancer	1.33e-05	0.00045	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—POMC—adrenal gland cancer	1.32e-05	0.000448	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	1.31e-05	0.000444	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—PRKACA—adrenal gland cancer	1.31e-05	0.000444	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—ABCB1—adrenal gland cancer	1.3e-05	0.000442	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	1.28e-05	0.000434	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—PRKACA—adrenal gland cancer	1.23e-05	0.000418	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—PRKACA—adrenal gland cancer	1.22e-05	0.000414	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—GNAS—adrenal gland cancer	1.22e-05	0.000413	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	1.2e-05	0.000405	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—ABCB1—adrenal gland cancer	1.2e-05	0.000405	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—PTGS2—adrenal gland cancer	1.16e-05	0.000393	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—MED12—adrenal gland cancer	1.11e-05	0.000375	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—GNAS—adrenal gland cancer	1.09e-05	0.000368	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—ABCB1—adrenal gland cancer	1.07e-05	0.000362	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—GNAS—adrenal gland cancer	1.06e-05	0.00036	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—PTGS2—adrenal gland cancer	1.05e-05	0.000357	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—PRKACA—adrenal gland cancer	1.05e-05	0.000354	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	1.02e-05	0.000346	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—GNAS—adrenal gland cancer	1e-05	0.000339	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—GNAS—adrenal gland cancer	9.92e-06	0.000336	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—ABCB1—adrenal gland cancer	9.81e-06	0.000333	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—ABCB1—adrenal gland cancer	9.73e-06	0.00033	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—POMC—adrenal gland cancer	8.95e-06	0.000303	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—GNAS—adrenal gland cancer	8.47e-06	0.000287	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—ABCB1—adrenal gland cancer	8.31e-06	0.000282	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—POMC—adrenal gland cancer	8.2e-06	0.000278	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—PRKACA—adrenal gland cancer	8.07e-06	0.000273	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—POMC—adrenal gland cancer	7.32e-06	0.000248	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—POMC—adrenal gland cancer	7.15e-06	0.000242	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—PTGS2—adrenal gland cancer	7.14e-06	0.000242	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—POMC—adrenal gland cancer	6.73e-06	0.000228	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—POMC—adrenal gland cancer	6.68e-06	0.000226	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—PTGS2—adrenal gland cancer	6.54e-06	0.000222	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—GNAS—adrenal gland cancer	6.54e-06	0.000222	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—ABCB1—adrenal gland cancer	6.42e-06	0.000217	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—PTGS2—adrenal gland cancer	5.84e-06	0.000198	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—POMC—adrenal gland cancer	5.71e-06	0.000193	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—PTGS2—adrenal gland cancer	5.7e-06	0.000193	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—PTGS2—adrenal gland cancer	5.37e-06	0.000182	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—PTGS2—adrenal gland cancer	5.32e-06	0.00018	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—PTGS2—adrenal gland cancer	4.55e-06	0.000154	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—POMC—adrenal gland cancer	4.4e-06	0.000149	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—PTGS2—adrenal gland cancer	3.51e-06	0.000119	CbGpPWpGaD
